how long will semaglutide be on fda shortage list resolved feb 21 2025 As of February 21, 2025, the updated its drug FDA says shortage of Ozempic

But heres the catch: many believe these medications are a one-and-done solution

Regional and Supply Factors: Local NHS commissioning decisions affect availabilitysome integrated care boards (ICBs) have restricted access to GLP-1 medications for weight management due to budget constraints

Individuals on Reddit are also not prompted or required to disclose all their side effects

Evolv's claim to engage both GLP-1 and GIP receptors positions it as a biomimetic dual agonist, similar in concept to tirzepatide but delivered through an entirely different mechanism

Predominantly gastrointestinal nausea, diarrhea, vomiting, constipation, and decreased appetite all dose-dependent and most common after a dose or an escalation

However, as with all research compounds, it is essential to approach their use with caution, prioritize product quality, and remain mindful of regulatory and safety considerations